THE PROBLEM
Access to medicine is not only a low-income-country issue. Around the world, patients go without treatment because health systems cannot consistently deliver affordable care. In the United States, affordability also breaks access: many people delay care, skip prescriptions, or change how they take medicines because of cost.
THE SOLUTION
Access4One is a partnership platform for affordable launch. It aligns Philanthropy, Research, Manufacturing, Distribution, Policy, and Implementation Partners to reduce the cost of moving important therapies from development to patient access.
THE FIRST THREE PILOTS
1) Cardiovascular Affordability Accelerator
2) Diabetes Continuity and Insulin Access Pathway
3) Secondary Prevention Polypill Access Pilot
HELP BUILD THE NEXT GENERATION OF MEDICINE AFFORDABILITY
DISEASE FOCUSES
OUR PARTNERSHIP PLATFORM FOR AFFORDABLE ACCESS
Access4One Works With Partners Across Philanthropy, Research, Manufacturing, Distribution, Policy, and Care Delivery to Build Sustainable Pathways That Make Essential Medicines More Affordable and Accessible.
Affordable Patient Access
Affordable Patient Access
We build practical, partnership-driven pathways that help patients obtain essential medicines at lower cost while strengthening delivery systems for long-term access.Technology That Lowers Cost
Modelling
Access4One applies artificial intelligence and analytics to reduce waste, improve decision-making, and support more affordable medicine development and access.Strategic Partnerships
Alliances
We bring together industry, governments, non-profits, health systems, and implementation partners to align expertise, reduce friction, and expand affordable access to essential medicines.
Digital Health and Care Delivery
Disease Applications
We support digital and care-delivery tools that improve efficiency in treatment, adherence, and disease management so more patients can benefit from affordable medicines.
“We make a living by what we get. We make a life by what we give.”
JOIN US IN BUILDING THE NEXT GENERATION OF AFFORDABLE MEDICINE ACCESS